Recombinant outer membrane protein F-B subunit of LT protein as a prophylactic measure against Pseudomonas aeruginosa burn infection in mice.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  World Journal of Methodology

• Publication date

  2015-12-26

• Fields of study

  Medicine

• Identifiers
  DOI 10.5662/wjm.v5.i4.230PMID 26713284PMCID PMC4686421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A PLGA-encapsulated chimeric protein protects against adherence and toxicity of enterotoxigenic Escherichia coli.

  2014cited by this paper
• Novel adjuvants & delivery vehicles for vaccines development: A road ahead

  2013cited by this paper
• Effects of azithromycin in Pseudomonas aeruginosa burn wound infection.

  2013cited by this paper
• Antimicrobial susceptibility of bacterial isolates from burn units in Gaza.

  2013cited by this paper
• The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections

  2012cited by this paper
• Characterization of a Mutant Escherichia coli Heat-Labile Toxin, LT(R192G/L211A), as a Safe and Effective Oral Adjuvant

  2011cited by this paper
• Poly-N-Acetyl-β-(1-6)-Glucosamine Is a Target for Protective Immunity against Acinetobacter baumannii Infections

  2011cited by this paper
• Enhancement of Immune Responses by an Attenuated Salmonella enterica Serovar Typhimurium Strain Secreting an Escherichia coli Heat-Labile Enterotoxin B Subunit Protein as an Adjuvant for a Live Salmonella Vaccine Candidate

  2010cited by this paper
• Comparison of the immune responses induced by oral immunization of mice with Lactobacillus casei-expressing porcine parvovirus VP2 and VP2 fused to Escherichia coli heat-labile enterotoxin B subunit protein

  2010cited by this paper
• A Fusion Protein Vaccine Containing OprF Epitope 8, OprI, and Type A and B Flagellins Promotes Enhanced Clearance of Nonmucoid Pseudomonas aeruginosa

  2009cited by this paper
• Immune responses in the airways by nasal vaccination with systemic boosting against Pseudomonas aeruginosa in chronic lung disease.

  2009cited by this paper
• Recombinant porcine rotavirus VP4 and VP4-LTB expressed in Lactobacillus casei induced mucosal and systemic antibody responses in mice

  2009cited by this paper
• Immunization of young African green monkeys with OprF epitope 8-OprI-type A- and B-flagellin fusion proteins promotes the production of protective antibodies against nonmucoid Pseudomonas aeruginosa.

  2009cited by this paper
• Flagellin-F1-V Fusion Protein Is an Effective Plague Vaccine in Mice and Two Species of Nonhuman Primates

  2008cited by this paper
• A double-blind randomized placebo-controlled phase III study of a Pseudomonas aeruginosa flagella vaccine in cystic fibrosis patients

  2007cited by this paper
• Intranasal immunization with heterologously expressed polysaccharide protects against multiple Pseudomonas aeruginosa infections

  2007cited by this paper
• Antibody responses induced by long-term vaccination with an octovalent conjugate Pseudomonas aeruginosa vaccine in children with cystic fibrosis.

  2006cited by this paper
• B subunit of E. coli enterotoxin as adjuvant and carrier in oral and skin vaccination.

  2006cited by this paper
• Mucosal adjuvants.

  2005cited by this paper
• Longitudinal development of mucoid Pseudomonas aeruginosa infection and lung disease progression in children with cystic fibrosis.

  2005cited by this paper
• Mucosal adjuvants.

  2005cited by this paper
• Enhanced Immunogenicity in the Murine Airway Mucosa with an Attenuated Salmonella Live Vaccine Expressing OprF-OprI from Pseudomonas aeruginosa

  2004cited by this paper
• Changes of microbial flora and wound colonization in burned patients.

  2004cited by this paper
• Mucosal immunisation: adjuvants and delivery systems.

  2004cited by this paper
• Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.

  2004cited by this paper
• Aerobic bacterial isolates from burn wound infections and their antibiograms--a five-year study.

  2004cited by this paper
• Vaccination of Cystic Fibrosis Patients Against Pseudomonas aeruginosa Reduces the Proportion of Patients Infected and Delays Time to Infection

  2004cited by this paper
• More Is Not Necessarily Better: Prozone-Like Effects in Passive Immunization with IgG1

  2003cited by this paper
• Clinical study to assess the immunogenicity and safety of a recombinant Pseudomonas aeruginosa OprF-OprI vaccine in burn patients.

  2003cited by this paper
• Immune modulation by the cholera-like enterotoxin B-subunits: from adjuvant to immunotherapeutic.

  2000cited by this paper
• Then and now: studies using a burned mouse model reflect trends in burn research over the past 25 years.

  1999cited by this paper
• Immune modulation by the cholera-like enterotoxins: from adjuvant to therapeutic.

  1999cited by this paper
• Pseudomonas aeruginosa antigens as potential vaccines.

  1997cited by this paper
• Immunoreactivity, epitope mapping and protection studies with anti-conotoxin GI sera and various conotoxins.

  1992cited by this paper
• Antibody response of infected mice to outer membrane proteins of Pseudomonas aeruginosa

  1984cited by this paper
• A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

  1976cited by this paper

• EPY001, a Novel Monoclonal Antibody Against Pseudomonas aeruginosa Targeting OprF

  2025cites this paper
• Does Every Strain of Pseudomonas aeruginosa Attack the Same? Results of a Study of the Prevalence of Virulence Factors of Strains Obtained from Different Animal Species in Northeastern Poland

  2024cites this paper
• Adjuvanted leptospiral vaccines: Challenges and future development of new leptospirosis vaccines.

  2019cites this paper
• In-silico design, expression, and purification of novel chimeric Escherichia coli O157:H7 OmpA fused to LTB protein in Escherichia coli

  2017cites this paper